Sabra Net Interest Income from 2010 to 2026
| SBRA Stock | USD 18.45 0.06 0.32% |
Net Interest Income | First Reported 2019-03-31 | Previous Quarter -27.5 M | Current Value -28.9 M | Quarterly Volatility 2.8 M |
Check Sabra Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sabra Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 134.9 M, Interest Expense of 86.1 M or Selling General Administrative of 31.2 M, as well as many indicators such as Price To Sales Ratio of 9.78, Dividend Yield of 0.0985 or PTB Ratio of 1.53. Sabra financial statements analysis is a perfect complement when working with Sabra Healthcare Valuation or Volatility modules.
Sabra | Net Interest Income | Build AI portfolio with Sabra Stock |
Latest Sabra Healthcare's Net Interest Income Growth Pattern
Below is the plot of the Net Interest Income of Sabra Healthcare REIT over the last few years. It is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. Sabra Healthcare's Net Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sabra Healthcare's overall financial position and show how it may be relating to other accounts over time.
| Net Interest Income | 10 Years Trend |
|
Net Interest Income |
| Timeline |
Sabra Net Interest Income Regression Statistics
| Arithmetic Mean | (91,865,108) | |
| Coefficient Of Variation | (28.67) | |
| Mean Deviation | 22,631,749 | |
| Median | (98,632,000) | |
| Standard Deviation | 26,339,290 | |
| Sample Variance | 693.8T | |
| Range | 82.2M | |
| R-Value | (0.72) | |
| Mean Square Error | 352.3T | |
| R-Squared | 0.52 | |
| Significance | 0 | |
| Slope | (3,775,404) | |
| Total Sum of Squares | 11100.1T |
Sabra Net Interest Income History
About Sabra Healthcare Financial Statements
Sabra Healthcare stakeholders use historical fundamental indicators, such as Sabra Healthcare's Net Interest Income, to determine how well the company is positioned to perform in the future. Although Sabra Healthcare investors may analyze each financial statement separately, they are all interrelated. For example, changes in Sabra Healthcare's assets and liabilities are reflected in the revenues and expenses on Sabra Healthcare's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Sabra Healthcare REIT. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | -103.7 M | -108.9 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Sabra Healthcare REIT offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sabra Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sabra Healthcare Reit Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sabra Healthcare Reit Stock:Check out the analysis of Sabra Healthcare Correlation against competitors. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sabra Healthcare. If investors know Sabra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Sabra Healthcare assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.29) | Dividend Share 1.2 | Earnings Share 0.73 | Revenue Per Share | Quarterly Revenue Growth 0.073 |
Understanding Sabra Healthcare REIT requires distinguishing between market price and book value, where the latter reflects Sabra's accounting equity. The concept of intrinsic value—what Sabra Healthcare's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Sabra Healthcare's price substantially above or below its fundamental value.
Please note, there is a significant difference between Sabra Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sabra Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Sabra Healthcare's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.